ITTP: Invasive Techniques in Trigger Points

Sponsor
Maimonides University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05478928
Collaborator
(none)
60
1
6
12
5

Study Details

Study Description

Brief Summary

Myofascial pain syndrome (MPS) is present in up to 87% of the patients that present pain. MPS usually presents painful myofascial trigger points (MTrPs).

One methodology used to quantify the pain in MPS is the algometry, which measures the pressure pain threshold (PPT).

Invasive techniques in physiotherapy have become popular in the last years due to their clinical efficacy and evidence. Percutaneous Microelectrolysis (MEP®) and dry needling are techniques that are already in use for this syndrome.

MEP® is a technique that employs a galvanic current up to 990 microAmperes, which is applied percutaneously with an acupuncture needle connected to the cathode. It is also known as low intensity percutaneous electrolysis.

The aim of this study is to compare the effects in pain and muscle tone (measured with algometry and surface electromyography) of invasive techniques. Healthy subjects between 18 to 48 years old, both sex, presenting MTrPs in upper trapezius will be recruited.

The secondary objectives are to determine the discomfort degree of each technique and if it is better to use MEP® with a fixed dose or with an algorithm in which the dose varies.

The hypothesis, according to our previous studies, is that MEP® generates higher changes in PPT.

Condition or Disease Intervention/Treatment Phase
  • Other: Dynamic dry needling
  • Device: Fixed dose dynamic MEP
  • Other: Static Dry needling
  • Device: Fixed dose static MEP
  • Device: Algorithm-based dose static MEP
  • Other: Placebo
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effects of Invasive Techniques in Myofascial Trigger Points: A Randomized Controlled Clinical Trial
Anticipated Study Start Date :
Aug 15, 2022
Anticipated Primary Completion Date :
Aug 15, 2023
Anticipated Study Completion Date :
Aug 15, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Dynamic dry needling

Dynamic dry needling will be done in the upper trapezius trigger point.

Other: Dynamic dry needling
An acupuncture needle of 0.3 x 25 mm will be introduced perpendicularly into the upper trapezius trigger point. A movement with the needle will be done at 1 Hz for 120 seconds.

Experimental: Fixed dose dynamic MEP

Dynamic low intensity percutaneous electrolysis will be applied in the upper trapezius trigger point with a fixed dose.

Device: Fixed dose dynamic MEP
Cathodic low intensity percutaneous electrolysis will be applied through an acupuncture needle of 0.3 x 25 mm in the upper trapezius trigger point. A movement with the needle will be done at 1 Hz with an intensity of 600 micro-Amperes. If the patient refers discomfort, the procedure will be stopped and resumed totalling 120 seconds (total dose of 72 mC).

Experimental: Static dry needling:

Static dry needling will be done in the upper trapezius trigger point.

Other: Static Dry needling
An acupuncture needle of 0.3 x 25 mm will be introduced perpendicularly into the upper trapezius trigger point for 120 seconds.

Experimental: Fixed dose static MEP

Static low intensity percutaneous electrolysis will be applied in the upper trapezius trigger point with a fixed dose.

Device: Fixed dose static MEP
Cathodic low intensity percutaneous electrolysis will be applied through an acupuncture needle of 0.3 x 25 mm in the upper trapezius trigger point. The therapy will be done statically with an intensity of 600 micro-Amperes. If the patient refers discomfort, the procedure will be stopped and resumed totalling 120 seconds (total dose of 72 mC).

Experimental: Algorithm-based dose static MEP

Low intensity percutaneous electrolysis will be applied in the upper trapezius trigger point with an algorithm-based dose.

Device: Algorithm-based dose static MEP
Cathodic low intensity percutaneous electrolysis will be applied through an acupuncture needle of 0.3 x 25 mm in the upper trapezius trigger point. The therapy will be done statically, at 600 micro-Amperes. If the patient refers discomfort, the procedure will be stopped and resumed. Treatment will finish when the patient does not refer any discomfort for a period longer than 60 seconds. Total dose in mC will be registered.

Placebo Comparator: Placebo

An acupuncture needle will be slightly introduced into the upper trapezius trigger point.

Other: Placebo
An acupuncture needle of 0.3 x 25 mm will be introduced perpendicularly up to 3 mm deep into the upper trapezius trigger point for 120 seconds.

Outcome Measures

Primary Outcome Measures

  1. Pressure Pain Threshold (PPT) - Baseline [Baseline]

    Algometry is used to measure the Pressure Pain Threshold (PPT). PPT is defined as the minimum force applied which induces pain. It will be applied in the Myofascial Trigger points.

  2. Pressure Pain Threshold (PPT) - 10 minutes [10 minutes]

    Algometry is used to measure the Pressure Pain Threshold (PPT). PPT is defined as the minimum force applied which induces pain. It will be applied in the Myofascial Trigger points.

  3. Pressure Pain Threshold (PPT) - 24 hours [24 hours]

    Algometry is used to measure the Pressure Pain Threshold (PPT). PPT is defined as the minimum force applied which induces pain. It will be applied in the Myofascial Trigger points.

  4. Pressure Pain Threshold (PPT) - 48 hours [48 hours]

    Algometry is used to measure the Pressure Pain Threshold (PPT). PPT is defined as the minimum force applied which induces pain. It will be applied in the Myofascial Trigger points.

  5. Pressure Pain Threshold (PPT) - Day 7 [Day 7]

    Algometry is used to measure the Pressure Pain Threshold (PPT). PPT is defined as the minimum force applied which induces pain. It will be applied in the Myofascial Trigger points.

  6. Surface electromyography at rest - Baseline [Baseline]

    Electromyography (EMG) is used to measure muscular electrical activity at rest to determine the basal tone. Peak voltage and root mean square (RMS) voltage will be informed.

  7. Surface electromyography at rest - 10 minutes [10 minutes]

    Electromyography (EMG) is used to measure muscular electrical activity at rest to determine the basal tone. Peak voltage and root mean square (RMS) voltage will be informed.

  8. Surface electromyography at rest - 24 hours [24 hours]

    Electromyography (EMG) is used to measure muscular electrical activity at rest to determine the basal tone. Peak voltage and root mean square (RMS) voltage will be informed.

  9. Surface electromyography at rest - 48 hours [48 hours]

    Electromyography (EMG) is used to measure muscular electrical activity at rest to determine the basal tone. Peak voltage and root mean square (RMS) voltage will be informed.

  10. Surface electromyography at rest - Day 7 [Day 7]

    Electromyography (EMG) is used to measure muscular electrical activity at rest to determine the basal tone. Peak voltage and root mean square (RMS) voltage will be informed.

  11. Surface electromyography at maximum voluntary contraction - Baseline [Baseline]

    Electromyography (EMG) is used to measure muscular electrical activity at maximum voluntary contraction to determine the recruitment. Peak voltage and RMS voltage will be informed.

  12. Surface electromyography at maximum voluntary contraction - 10 minutes [10 minutes]

    Electromyography (EMG) is used to measure muscular electrical activity at maximum voluntary contraction to determine the recruitment. Peak voltage and RMS voltage will be informed.

  13. Surface electromyography at maximum voluntary contraction - 24 hours [24 hours]

    Electromyography (EMG) is used to measure muscular electrical activity at maximum voluntary contraction to determine the recruitment. Peak voltage and RMS voltage will be informed.

  14. Surface electromyography at maximum voluntary contraction - 48 hours [48 hours]

    Electromyography (EMG) is used to measure muscular electrical activity at maximum voluntary contraction to determine the recruitment. Peak voltage and RMS voltage will be informed.

  15. Surface electromyography at maximum voluntary contraction - Day 7 [Day 7]

    Electromyography (EMG) is used to measure muscular electrical activity at maximum voluntary contraction to determine the recruitment. Peak voltage and RMS voltage will be informed.

Secondary Outcome Measures

  1. Visual Analogue Scale of the procedure [Immediately after the intervention]

    To determine how unpleasant the procedure is, the visual analog scale (VAS) will be used. Expresed in centimeters. Minimum value: 0 Maximum value: 10 A higher score implicates a worse outcome.

  2. Post-needling soreness [Four times per day (in the morning, before lunch, in the afternoon, and in the evening) during the seven days following intervention.]

    To determine how unpleasant the post-needling soreness is, a pain diary with the visual analog scale (VAS) will be used. The patient will register the pain intensity in the needle area. Expresed in centimeters. Minimum value: 0 Maximum value: 10 A higher score implicates a worse outcome.

  3. Dose [Immediately after the intervention]

    To determine the amount of electric charge applied, the millicoulombs (mC) informed in the MEP device will be recorded.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 48 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. Neck pain during the last 6 months

  2. Presence of a palpable taut band in the upper trapezius

  3. Presence of a hypersensitive tender spot in the taut band, with local or referred pain elicitation in response to compression

  4. PPT less than 3 Kg/cm2

Exclusion Criteria:
  1. Previous cervical and/or shoulder surgical intervention.

  2. Phobia to needles.

  3. Temporomandibular disorders.

  4. Medicated with anticoagulants

  5. Still receiving a treatment for the myofascial trigger points (Physical therapy, NSAIDs, etc.)

  6. Diagnosis of fibromyalgia.

  7. Radiculopathies and/or radicular pain

  8. Whiplash related neck pain

  9. Migraines

  10. Dizziness

  11. Endocrinal diseases

  12. Being pregnant

  13. Cancer

Contacts and Locations

Locations

Site City State Country Postal Code
1 Universidad Maimónides Ciudad Autonoma de Buenos Aires Caba Argentina 1405

Sponsors and Collaborators

  • Maimonides University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Oscar Ronzio, Head of Physiotherapy program, Maimonides University
ClinicalTrials.gov Identifier:
NCT05478928
Other Study ID Numbers:
  • 863
First Posted:
Jul 28, 2022
Last Update Posted:
Jul 28, 2022
Last Verified:
Jul 1, 2022
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No
Keywords provided by Oscar Ronzio, Head of Physiotherapy program, Maimonides University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jul 28, 2022